Skip to main content

Table III Characteristics of subjects in the final test

From: Variability of serum CYFRA 21 − 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis

  

Total

Not frequently elevated

Frequently elevated

p-value

Number of subjects

 

951

892

59

 

Sex (male, %)

 

77.5

77.5

78.0

1.000

Age at the baseline

     

 Median [IQR] (years)

54 [47, 61]

54 [47, 60]

61 [55, 67]

< 0.001

 Categories (%)

< 50

31.4

32.5

15.2

< 0.001

 

50–64

54.4

54.9

45.8

 
 

≥ 65

14.2

12.6

39.0

 

BMI at the baseline

     

 Median [IQR]

 

23.1 [21.3, 25.2]

23.2 [21.4, 25.2]

22.0 [20.8, 25.1]

0.111

 Categories (%)

< 25

73.2

73.2

72.9

1.000

 

≥ 25

26.8

26.8

27.1

 

Weight change in the follow-up period

    
 

Maintenance or gain

58.1

59.2

42.4

0.016

 

Loss

41.9

40.8

57.6

 

Smoking status at the baseline

     

 Categories (%)

Non-smoker

39.6

40.2

30.5

0.057

 

Ex-smoker

40.7

40.8

39.0

 
 

Current (pack-year < 20)

7.1

7.1

6.8

 
 

Current (pack-year ≥ 20)

12.6

11.9

23.7

 

Number of times (CYFRA 21 − 1 > 3.5 ng/ml)

    

 the rate of numbers (%)

0

84.9

90.5

0

< 0.001

 

1

8.9

9.5

0

 
 

2

3.7

0

59.3

 
 

3

1.9

0

30.5

 
 

4

0.4

0

6.8

 
 

5

0.2

0

3.4

 

Number of times (CEA > 5.0 ng/ml)

    

 the rate of numbers (%)

0

98.8

98.9

96.6

0.198

 

1

0.6

0.6

1.7

 
 

2

0.1

0.1

0

 
 

3

0

0

0

 
 

4

0.2

0.2

0

 
 

5

0.3

0.2

1.7